{"id":"W3213907938","doi":"10.1016/s2468-1253(21)00294-6","title":"Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study","year":2021,"lang":"en","type":"article","venue":"The Lancet. Gastroenterology & hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"F. Hoffmann-La Roche; Roche","keywords":"Double blind; Ulcerative colitis; Infliximab; Medicine; Internal medicine; Gardenia; Gastroenterology; Double blind study; Traditional medicine; Dermatology; Placebo; Tumor necrosis factor alpha; Pathology; Disease; Traditional Chinese medicine; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003428744,0.0005312299,0.001063749,0.00008824594,0.0003735331,0.00004630937,0.0006104061,0.0002680575,0.00006004846],"category_scores_gemma":[0.00004374909,0.0003877137,0.0004429718,0.0001232847,0.000428299,0.00001250394,0.0002336412,0.0002189367,0.0000158013],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001531821,"about_ca_system_score_gemma":0.0004012185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008477458,"about_ca_topic_score_gemma":0.009634444,"domain_scores_codex":[0.9963475,0.0008141708,0.0006994376,0.0009275633,0.000213761,0.000997555],"domain_scores_gemma":[0.9974269,0.0002412086,0.0003520004,0.001223175,0.0005534449,0.0002033119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9836314,0.002155697,0.005546453,0.00002114373,0.002847896,0.000286988,0.001364755,0.0005943439,0.001100132,0.0001110914,0.001547726,0.0007923972],"study_design_scores_gemma":[0.904693,0.02227317,0.03545214,0.0000125205,0.001500208,0.0003138672,0.001955553,0.001187724,0.01431065,0.00006932136,0.01772566,0.000506197],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903538,0.0001890874,0.00200481,0.001643736,0.0008188205,0.004343182,0.0004072035,0.0000291623,0.0002101908],"genre_scores_gemma":[0.9934726,0.0001534378,0.0001601984,0.001133528,0.000613852,0.003939833,0.0002399392,0.00005963718,0.0002269869],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07893839,"threshold_uncertainty_score":0.9998575,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04717041392585142,"score_gpt":0.3312742166730299,"score_spread":0.2841038027471785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}